Flagship framework · Host Capacity Model
Mitochondrial Barrier Failure
Tight-junction failure is downstream of epithelial mitochondrial insufficiency, not a primary lesion.
- ▸Tight junctions are ATP-dependent structures.
- ▸When mitochondria fail, barriers fail predictably.
- ▸Barrier therapeutics without bioenergetic support stall.
Core Insight
Barrier integrity is a function of bioenergetic capacity, not a parallel system.
Conceptual narrative
The clinical category 'leaky gut' often hides a bioenergetic story: tight-junction maintenance, junctional remodeling, and epithelial turnover are all ATP-intensive.
Mechanistic layers
- Energy. ATP throughput supports junctional protein turnover and remodeling.
- Failure. Bioenergetic insufficiency manifests as junctional disorganization.
- Symptom. Increased permeability; downstream immune activation.
Foundational Mechanism
Tight-junction maintenance and remodeling are ATP-dependent processes.
Evidence map
- establishedATP-dependence of tight junction maintenance. Cell biology consensus.
Key Contradiction
Barrier-only interventions repeatedly underperform expectations in low-capacity patients.
Systems-Level Interpretation
Permeability is a readout of host energy state, not just an injury marker.
Mechanistic Prediction
Bioenergetic restoration should reduce permeability without direct barrier-targeting agents.
Conceptual Limitation
Acute mechanical or chemical injury bypasses this framework.
Canonical terminology
- mitochondrial barrier failure
- Mitochondrial barrier failure positions tight-junction loss as a downstream consequence of epithelial ATP insufficiency, not as a primary lesion — barrier integrity tracks bioenergetic capacity.
- colonocyte bioenergetics
- Colonocyte bioenergetics describes how colonic epithelial mitochondria oxidize butyrate to maintain steep epithelial oxygen consumption, sustaining the lumen's near-anaerobic state that selects for obligate anaerobic commensals.
- Host Capacity Model (HCM)
- The Host Capacity Model (HCM) holds that recurrent SIBO, MCAS, post-viral illness, and persistent dysbiosis are downstream consequences of failing host bioenergetic capacity at the gut epithelium — not primary microbial diseases.
FAQ
Are barrier-protective compounds useless?
No, but their effect ceiling is set by host bioenergetic capacity.
Citation
Attallah, M. Mitochondrial Barrier Failure. BiomeLogic, Host Capacity Model. https://biomelogic.net/flagship/mitochondrial-barrier-failure
Update timeline
- — Flagship layout introduced.